167 related articles for article (PubMed ID: 35780179)
1. Combinations of scleroderma hallmark autoantibodies associate with distinct clinical phenotypes.
Clark KEN; Campochiaro C; Host LV; Sari A; Harvey J; Denton CP; Ong VH
Sci Rep; 2022 Jul; 12(1):11212. PubMed ID: 35780179
[TBL] [Abstract][Full Text] [Related]
2. Autoantibody profiles in systemic sclerosis: predictive value for clinical evaluation and prognosis.
Hamaguchi Y
J Dermatol; 2010 Jan; 37(1):42-53. PubMed ID: 20175839
[TBL] [Abstract][Full Text] [Related]
3. Clinical and serological features of systemic sclerosis in a Chinese cohort.
Wang J; Assassi S; Guo G; Tu W; Wu W; Yang L; Xiao R; Zhao Y; Chu H; Liu J; Ma Y; Kim SJ; Jin L; Mayes MD; Zou H; Zhou X
Clin Rheumatol; 2013 May; 32(5):617-21. PubMed ID: 23271609
[TBL] [Abstract][Full Text] [Related]
4. [Autoantibodies and their clinical characteristics in systemic sclerosis].
Hamaguchi Y
Nihon Rinsho Meneki Gakkai Kaishi; 2013; 36(3):139-47. PubMed ID: 23812071
[TBL] [Abstract][Full Text] [Related]
5. Gender and ethnicity differences in the prevalence of scleroderma-related autoantibodies.
Krzyszczak ME; Li Y; Ross SJ; Ceribelli A; Chan EK; Bubb MR; Sobel ES; Reeves WH; Satoh M
Clin Rheumatol; 2011 Oct; 30(10):1333-9. PubMed ID: 21523365
[TBL] [Abstract][Full Text] [Related]
6. Extended autoantibody panel in Turkish patients with early-stage systemic sclerosis: Coexpressions and their influences on clinical phenotypes.
Temiz Karadağ D; Komac A; Erez Y; Birlik AM; Sari A; Akdoğan A; Farisogullari B; Kimyon G; Koc E; Arslan D; Karatas A; Koca SS; Kasifoglu N; Yazici A; Hayran KM; Cefle A
Immun Inflamm Dis; 2023 Dec; 11(12):e1089. PubMed ID: 38134320
[TBL] [Abstract][Full Text] [Related]
7. Influence of antibody profile in clinical features and prognosis in a cohort of Spanish patients with systemic sclerosis.
Iniesta Arandia N; Simeón-Aznar CP; Guillén Del Castillo A; Colunga Argüelles D; Rubio-Rivas M; Trapiella Martínez L; García Hernández FJ; Sáez Comet L; Egurbide Arberas MV; Ortego-Centeno N; Freire M; Marí Alfonso B; Vargas Hitos JA; Ríos Blanco JJ; Todolí Parra JA; Rodríguez-Carballeira M; Marín Ballvé A; Chamorro Fernández AJ; Pla Salas X; Madroñero Vuelta AB; Ruiz Muñoz M; Fonollosa Pla V; Espinosa G;
Clin Exp Rheumatol; 2017; 35 Suppl 106(4):98-105. PubMed ID: 28980912
[TBL] [Abstract][Full Text] [Related]
8. South Australian Scleroderma Register: autoantibodies as predictive biomarkers of phenotype and outcome.
Graf SW; Hakendorf P; Lester S; Patterson K; Walker JG; Smith MD; Ahern MJ; Roberts-Thomson PJ
Int J Rheum Dis; 2012 Feb; 15(1):102-9. PubMed ID: 22324953
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic accuracy and predictive value of extended autoantibody profile in systemic sclerosis.
Villalta D; Imbastaro T; Di Giovanni S; Lauriti C; Gabini M; Turi MC; Bizzaro N
Autoimmun Rev; 2012 Dec; 12(2):114-20. PubMed ID: 22776784
[TBL] [Abstract][Full Text] [Related]
10. Relevance of clinical and autoantibody profiles in systemic sclerosis among Thais.
Foocharoen C; Watcharenwong P; Netwijitpan S; Mahakkanukrauh A; Suwannaroj S; Nanagara R
Int J Rheum Dis; 2017 Oct; 20(10):1572-1581. PubMed ID: 28296274
[TBL] [Abstract][Full Text] [Related]
11. Autoantibody predictors of gastrointestinal symptoms in systemic sclerosis.
Ahmed F; Maclean RH; Nihtyanova SI; Ong VH; Murray CD; Denton CP
Rheumatology (Oxford); 2022 Feb; 61(2):781-786. PubMed ID: 33909895
[TBL] [Abstract][Full Text] [Related]
12. Autoantibodies as predictive tools in systemic sclerosis.
Nihtyanova SI; Denton CP
Nat Rev Rheumatol; 2010 Feb; 6(2):112-6. PubMed ID: 20125179
[TBL] [Abstract][Full Text] [Related]
13. Clinical features of Japanese systemic sclerosis (SSc) patients negative for SSc-related autoantibodies: A single-center retrospective study.
Miyake M; Matsushita T; Takehara K; Hamaguchi Y
Int J Rheum Dis; 2020 Aug; 23(9):1219-1225. PubMed ID: 32662135
[TBL] [Abstract][Full Text] [Related]
14. Autoantibody profiles in systemic sclerosis; a comparison of diagnostic tests.
Alkema W; Koenen H; Kersten BE; Kaffa C; Dinnissen JWB; Damoiseaux JGMC; Joosten I; Driessen-Diks S; van der Molen RG; Vonk MC; Smeets RL
Autoimmunity; 2021 May; 54(3):148-155. PubMed ID: 33818234
[TBL] [Abstract][Full Text] [Related]
15. Systemic Sclerosis-Specific Antibodies: Novel and Classical Biomarkers.
Cavazzana I; Vojinovic T; Airo' P; Fredi M; Ceribelli A; Pedretti E; Lazzaroni MG; Garrafa E; Franceschini F
Clin Rev Allergy Immunol; 2023 Jun; 64(3):412-430. PubMed ID: 35716254
[TBL] [Abstract][Full Text] [Related]
16. Scleroderma-specific autoantibodies embedded in immune complexes mediate endothelial damage: an early event in the pathogenesis of systemic sclerosis.
Raschi E; Privitera D; Bodio C; Lonati PA; Borghi MO; Ingegnoli F; Meroni PL; Chighizola CB
Arthritis Res Ther; 2020 Nov; 22(1):265. PubMed ID: 33168071
[TBL] [Abstract][Full Text] [Related]
17. Autoantibodies to the Rpp25 component of the Th/To complex are the most common antibodies in patients with systemic sclerosis without antibodies detectable by widely available commercial tests.
Mahler M; Satoh M; Hudson M; Baron M; Chan JY; Chan EK; Wick J; Fritzler MJ;
J Rheumatol; 2014 Jul; 41(7):1334-43. PubMed ID: 24931955
[TBL] [Abstract][Full Text] [Related]
18. Association between autoantibodies in systemic sclerosis and cancer in a national registry.
Hoa S; Lazizi S; Baron M; Wang M; Fritzler MJ; Hudson M;
Rheumatology (Oxford); 2022 Jul; 61(7):2905-2914. PubMed ID: 34599801
[TBL] [Abstract][Full Text] [Related]
19. Cutaneous Features, Autoantibody Profile, and Nailfold Capillaroscopy of Systemic Sclerosis: A Study of 60 Cases.
Dave J; Mahajan S; Khadilkar P; Pradhan V
J Assoc Physicians India; 2022 Nov; 70(11):11-12. PubMed ID: 37355940
[TBL] [Abstract][Full Text] [Related]
20. Clinical differences between Thai systemic sclerosis patients with positive versus negative anti-topoisomerase I.
Foocharoen C; Suwannachat P; Netwijitpan S; Mahakkanukrauh A; Suwannaroj S; Nanagara R;
Int J Rheum Dis; 2016 Mar; 19(3):312-20. PubMed ID: 25293362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
